Impact of Education Methods on HPV Knowledge and Screening Behavior (NCT07017387) | Clinical Trial Compass
CompletedNot Applicable
Impact of Education Methods on HPV Knowledge and Screening Behavior
Turkey (Türkiye)90 participantsStarted 2025-05-09
Plain-language summary
The aim of this study is to evaluate the effect of two different health education methods (one based on motivational interviewing) on women's HPV knowledge, cervical cancer health beliefs, and screening behaviors in women aged 30-65. A total of 90 healthy women who are registered at the Incirli Family Health Center in Ankara, meet the inclusion criteria, and volunteer to participate will be randomly assigned to three groups (30 participants per group).
The control group will receive standard healthcare services. The first intervention group will receive three sessions of motivational interviewing-based health education on cervical cancer prevention through home visits, along with an informational brochure. The second intervention group will receive health education and a brochure, followed by a reminder session via phone. At the end of the study, participants in the control group will be offered the intervention of their choice.
Who can participate
Age range
30 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being between 30 and 65 years of age
* Being literate
* Agreeing to participate in the study
* Being female
* Being married
* Having no history of cervical cancer in first-degree relatives (mother/sister)
* Not having undergone cervical cancer screening in the last five years
* Not having been diagnosed with cancer
Exclusion Criteria:
* Being pregnant or in the postpartum period
* Having been diagnosed with any type of cancer
* Having a hearing or speech impairment, or a mental disorder
* Using medication due to psychotic treatments
* Having undergone a hysterectomy
* Having had cervical cancer screening within the last five years
* Having received all three doses of the HPV vaccine
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in screening behavior
Timeframe: 8 weeks after intervention
Trial details
NCT IDNCT07017387
SponsorSaglik Bilimleri Universitesi Gulhane Tip Fakultesi